Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Alterity, Athenex, Aurigene Discovery, Beijing CC-Pharming, Bill & Melinda Gates Foundation, Bridge Biotherapeutics, China Grand, Clover, Curis, Ibio, Oncosec, Porton Pharma Solutions, Q Biomed, Recce.
Biopharmas in Asia-Pacific raising money in public or private financings, including: Astellas Pharma, Ikarovec.
Quarterly snapshots from biopharma companies with marketed products, including: Seattle Genetics, Takeda Pharmaceutical.
The latest global regulatory news, changes and updates affecting biopharma, including: Aurolife, CDC, Central Drugs Standard Control Organisation, FDA, Glaxosmithkline, National Institute of Allergy and Infectious Diseases, Sanofi, U.S. Court of Appeals, World Health Organization.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Zai Lab.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Aptorum, Biocryst, Zai Lab.